Corner Therapeutics

Corner Therapeutics is a privately held biotechnology company developing a novel, multi-purpose dendritic cell-targeting immunotherapy capable of inducing robust memory T-cell responses. Corner Therapeutics is leveraging a new scientific paradigm to enhance the intelligence of natural immune responses through the hyperactivation of dendritic cells. Our unique approach enables dendritic cell inflammasome induction of aberrant memory T-cell responses critical for lifelong immunity. Our platform is antigen-agnostic and designed to address a wide range of difficult-to-treat cancers and infectious diseases. Corner’s therapies will usher in a new era of rapid, patient-friendly, and low-cost treatments capable of inducing complete and durable protective immunity.